Literature DB >> 23916756

Consensus of official position of IOF/ISCD FRAX initiatives in Asia-Pacific region.

Chih-Hsing Wu1, Eugene V McCloskey2, Joon Kiong Lee3, Akira Itabashi4, Richard Prince5, Wei Yu6, Julie Li-Yu7, Siok Bee Chionh8, Yanling Zhao9, Chan Soo Shin10, Tirtarahardja Gunawan11, Keh-Sung Tsai12, Poon-Ung Chieng13, Sheng-Pin Changlai14, Ding-Cheng Chan15, Jung-Fu Chen16, S Bobo Tanner17, Didier B Hans18, John A Kanis19, Yin-Fan Chang20, Zih-Jie Sun21, Rong-Sen Yang22.   

Abstract

The fracture risk assessment tool (FRAX(®)) has been developed for the identification of individuals with high risk of fracture in whom treatment to prevent fractures would be appropriate. FRAX models are not yet available for all countries or ethnicities, but surrogate models can be used within regions with similar fracture risk. The International Society for Clinical Densitometry (ISCD) and International Osteoporosis Foundation (IOF) are nonprofit multidisciplinary international professional organizations. Their visions are to advance the awareness, education, prevention, and treatment of osteoporosis. In November 2010, the IOF/ISCD FRAX initiative was held in Bucharest, bringing together international experts to review and create evidence-based official positions guiding clinicians for the practical use of FRAX. A consensus meeting of the Asia-Pacific (AP) Panel of the ISCD recently reviewed the most current Official Positions of the Joint Official Positions of ISCD and IOF on FRAX in view of the different population characteristics and health standards in the AP regions. The reviewed position statements included not only the key spectrum of positions but also unique concerns in AP regions.
Copyright © 2014 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone mineral density; FRAX; clinical risk factor; fracture; osteoporosis

Mesh:

Year:  2013        PMID: 23916756     DOI: 10.1016/j.jocd.2013.06.002

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  10 in total

1.  Budget impact analysis of osteoporosis medications for primary prevention of fractures in Taiwan.

Authors:  Kun-Ling Wu; Chih-Hsing Wu; Yin-Fan Chang; Yun-Ting Lin; Jason C Hsu
Journal:  J Bone Miner Metab       Date:  2019-11-11       Impact factor: 2.626

2.  Validation of the Taiwan FRAX® calculator for the prediction of fracture risk.

Authors:  I-Ting Liu; Fu-Wen Liang; Chia-Chun Li; Yin-Fan Chang; Zih-Jie Sun; Tsung-Hsueh Lu; Chin-Sung Chang; Chih-Hsing Wu
Journal:  Arch Osteoporos       Date:  2022-01-29       Impact factor: 2.617

Review 3.  A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Authors:  John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2016-07-27       Impact factor: 2.617

Review 4.  Musculoskeletal imaging in preventive medicine.

Authors:  Franz Kainberger; Anna L Falkowski; Lena Hirtler; Georg Riegler; Thomas Schlegl; Siddharth Thaker; Janina Patsch; Richard Crevenna
Journal:  Wien Med Wochenschr       Date:  2016-01-27

5.  Effects of Age and Body Mass Index on Thoracolumbar Spine X-Ray for Diagnosing Osteoporosis in Elderly Women: Tianliao Old People (TOP) Study 07.

Authors:  Yin-Fan Chang; Chin-Sung Chang; Mei-Wen Wang; Chun-Feng Wu; Chuan-Yu Chen; Hsuan-Jui Chang; Po-Hsiu Kuo; Chih-Hsing Wu
Journal:  PLoS One       Date:  2016-09-08       Impact factor: 3.240

6.  The differences in the relationship between obstructive sleep apnea severity and trabecular bone score in men and women with type 2 diabetes.

Authors:  Hataikarn Nimitphong; Nantaporn Siwasaranond; Chanika Sritara; Sunee Saetung; La-Or Chailurkit; Naricha Chirakalwasan; Boonsong Ongphiphadhanakul; Sirimon Reutrakul
Journal:  J Clin Transl Endocrinol       Date:  2019-05-02

7.  Temporal changes in access to FRAX® in Thailand between 2010 and 2018.

Authors:  Pojchong Chotiyarnwong; Nicholas C Harvey; Helena Johansson; Enwu Liu; Mattias Lorentzen; John A Kanis; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2019-06-21       Impact factor: 2.617

8.  Relationship between the FRAX® score and falls in community-dwelling middle-aged and elderly people.

Authors:  Ling-Chun Ou; Yin-Fan Chang; Chin-Sung Chang; Ting-Hsing Chao; Ruey-Mo Lin; Zih-Jie Sun; Chih-Hsing Wu
Journal:  Osteoporos Sarcopenia       Date:  2016-12-10

Review 9.  The diversity of Fracture Risk Assessment Tool (FRAX)-based intervention thresholds in Asia.

Authors:  Sarath Lekamwasam
Journal:  Osteoporos Sarcopenia       Date:  2019-12-16

10.  The Role of Monocyte Percentage in Osteoporosis in Male Rheumatic Diseases.

Authors:  Yu-Jih Su; Chao Tung Chen; Nai-Wen Tsai; Chih-Cheng Huang; Hung-Chen Wang; Chia-Te Kung; Wei-Che Lin; Ben-Chung Cheng; Chih-Min Su; Sheng-Yuan Hsiao; Cheng-Hsien Lu
Journal:  Am J Mens Health       Date:  2017-09-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.